These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

993 related items for PubMed ID: 25540973

  • 1. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
    Akyuz U, Yesil A, Yilmaz Y.
    Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
    [Abstract] [Full Text] [Related]

  • 2. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL, Petta S, Lombardi R, Pisano G, Russello M, Consonni D, Di Marco V, Cammà C, Mensi L, Dongiovanni P, Valenti L, Craxì A, Fargion S.
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [Abstract] [Full Text] [Related]

  • 3. The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.
    Lin CL, Tai CM, Huang JF, Liu CJ, Chen HF, Cheng PN, Chen CY, Peng CY, Wang CC, Weng SH, Tseng TC, Kao JH.
    J Gastroenterol Hepatol; 2022 Oct; 37(10):1901-1910. PubMed ID: 35790343
    [Abstract] [Full Text] [Related]

  • 4. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J, Ranchal I, Gallego-Durán R, Pareja MJ, Del Campo JA, Pastor-Ramírez H, Rico MC, Picón R, Pastor L, García-Monzón C, Andrade R, Romero-Gómez M.
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [Abstract] [Full Text] [Related]

  • 5. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.
    Sookoian S, Pirola CJ.
    Aliment Pharmacol Ther; 2018 Jan; 47(1):16-25. PubMed ID: 29083036
    [Abstract] [Full Text] [Related]

  • 6. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.
    Shao C, Ye J, Li F, Feng S, Wang W, Zhong B.
    Dig Liver Dis; 2019 Oct; 51(10):1392-1399. PubMed ID: 30928418
    [Abstract] [Full Text] [Related]

  • 7. Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population.
    Li MR, Li JZ, Li JY, Wang CC, Yuan RK, Ye LH, Liu YY, Liang XJ, Zhang HC, Liu ZQ, Zeng DY, Zhang XD, Wang DH, Li JQ, Li TY, Yang L, Cao Y, Pan Y, Lin XG, Pan CQ, Dai EH, Dong ZY.
    Obes Facts; 2023 Oct; 16(5):427-434. PubMed ID: 37231905
    [Abstract] [Full Text] [Related]

  • 8. The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease.
    Margariti A, Deutsch M, Manolakopoulos S, Tiniakos D, Papatheodoridis GV.
    J Clin Gastroenterol; 2013 Mar; 47(3):280-6. PubMed ID: 23391869
    [Abstract] [Full Text] [Related]

  • 9. Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.
    Yılmaz Y, Kanı HT, Demirtaş CÖ, Kaya E, Sapmaz AF, Qutranji L, Alkayyali T, Batun KD, Batman M, Toy B, Çiftaslan A.
    Turk J Gastroenterol; 2019 Oct; 30(10):892-898. PubMed ID: 31258138
    [Abstract] [Full Text] [Related]

  • 10. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
    Chakrabarty M, Jha AN, Sharma DJ.
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
    [Abstract] [Full Text] [Related]

  • 11. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
    Leite NC, Villela-Nogueira CA, Pannain VL, Bottino AC, Rezende GF, Cardoso CR, Salles GF.
    Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
    [Abstract] [Full Text] [Related]

  • 12. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
    Younes R, Govaere O, Petta S, Miele L, Tiniakos D, Burt A, David E, Vecchio FM, Maggioni M, Cabibi D, McLeod D, Pareja MJ, Fracanzani AL, Aller R, Rosso C, Ampuero J, Gallego-Durán R, Armandi A, Caviglia GP, Zaki MYW, Liguori A, Francione P, Pennisi G, Grieco A, Birolo G, Fariselli P, Eslam M, Valenti L, George J, Romero-Gómez M, Anstee QM, Bugianesi E.
    Gut; 2022 Feb; 71(2):382-390. PubMed ID: 33541866
    [Abstract] [Full Text] [Related]

  • 13. Nonalcoholic fatty liver disease in lean individuals in the United States.
    Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B, Srishord M.
    Medicine (Baltimore); 2012 Nov; 91(6):319-327. PubMed ID: 23117851
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.
    Wang Z, Xu M, Hu Z, Shrestha UK.
    Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
    Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA.
    Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
    [Abstract] [Full Text] [Related]

  • 16. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN, Du SS, Wang C, Li YC, Liu LY, Guo FC, Sun CH.
    World J Gastroenterol; 2014 Dec 21; 20(47):17932-40. PubMed ID: 25548491
    [Abstract] [Full Text] [Related]

  • 17. Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients.
    Hirose S, Matsumoto K, Tatemichi M, Tsuruya K, Anzai K, Arase Y, Shiraishi K, Suzuki M, Ieda S, Kagawa T.
    PLoS One; 2020 Dec 21; 15(11):e0241770. PubMed ID: 33186403
    [Abstract] [Full Text] [Related]

  • 18. Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis.
    Rosenblatt R, Mehta A, Snell D, Hissong E, Kierans AS, Kumar S.
    Dig Dis Sci; 2019 Jan 21; 64(1):262-268. PubMed ID: 30269271
    [Abstract] [Full Text] [Related]

  • 19. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.
    Grattagliano I, Ubaldi E, Napoli L, Marulli CF, Nebiacolombo C, Cottone C, Portincasa P.
    Ann Hepatol; 2013 Jan 21; 12(1):70-7. PubMed ID: 23293196
    [Abstract] [Full Text] [Related]

  • 20. Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study.
    Petta S, Eslam M, Valenti L, Bugianesi E, Barbara M, Cammà C, Porzio M, Rosso C, Fargion S, George J, Craxì A.
    Liver Int; 2017 Sep 21; 37(9):1389-1396. PubMed ID: 28235154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.